DISCOUNT OPTIONSSCHEIN - ABBOTT LABORATORIES Stock

Certificat

DE000ME97YU6

Real-time Bid/Ask 04:33:07 2024-05-20 am EDT
0.56 EUR / 0.68 EUR +3.33% Intraday chart for DISCOUNT OPTIONSSCHEIN - ABBOTT LABORATORIES
Current month-34.07%
1 month-39.39%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 0.6 -3.23%
24-05-16 0.62 -1.59%
24-05-15 0.63 +1.61%
24-05-14 0.62 -8.82%
24-05-13 0.68 -2.86%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 02:22 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN ME97YU
ISINDE000ME97YU6
Date issued 2024-02-26
Strike 135 $
Maturity 2024-12-20 (215 Days)
Parity 1 : 1
Emission price 2.99
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.79
Lowest since issue 0.57
Spread 0.12
Spread %17.65%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.1 USD
Average target price
126.1 USD
Spread / Average Target
+21.19%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW